The blood centre as a community health resource

Vox Sanguinis

Volumn 91, Issue 3, 2006, Pages 206-213

  Davey, Richard J ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Blood centres; Blood donors; Community health; Health screening

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; GLUCOSE; HEMOGLOBIN; HOMOCYSTEINE;

BLOOD BANK; BLOOD CELL COUNT; BLOOD DONOR; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; DISEASE MARKER; EPIDEMIOLOGICAL DATA; GENETIC SCREENING; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEMOGLOBIN DETERMINATION; HUMAN; MASS SCREENING; MEDICAL INFORMATION; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; REVIEW; UNITED STATES;

BLOOD DONORS; COMMUNITY HEALTH CENTERS; COMMUNITY-INSTITUTIONAL RELATIONS; COUNSELING; HUMANS; MASS SCREENING; PATIENT EDUCATION; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 33748346433     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00824.x     Document Type: Review

References (38)

1. Wallace EL, Churchill WH, Surgenor DM, Cho GS, McGurk S: Collection and transfusion of blood and blood components in the United States 1994. Transfusion 1998; 38:625-636
2. Schaffler H, Louie J, Muscolino K: Partnering with the judicial system to recruit jurors as blood donors. Transfusion 2002; 42S-151S
3. Greco B, Louie J, Davey R: Creative methods to increase minority participation in blood drives. Blood Banks Assoc New York State Quarterly 2004; 38:4
4. Davey R, Kessler D, Henry R, Kessler R, Schaffler H, Louie J: 16-year-old donors: blood center experience at high school blood drives. Transfusion 2005; 45:168A
5. Meyers DG, Jensen KC, Menitove JE: A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42:1135-1139
6. Dodd RY: Epidemiology of transfusion-transmitted diseases; in Anderson KC, Ness PM (eds): Scientific Basis of Transfusion Medicine. Philadelphia, W.B. Saunders, 2000:455-471
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ and the National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2571
8. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002; 360:1903-1913
9. Geringer W, Shenfeld M, Kessler D, Baker K, Martin-Prendergast S, Davey R: Hypertension assessment and referral by a community blood center. Transfusion 2004; 44S: 81A
10. Newman BH: Adjusting our management of female blood donors: the key to an adequate blood supply. Transfusion 2004; 44:591-596
11. Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts R, Aylesworth C, Nemo G, Alving B: Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002; 42:798-805
12. Simon TL: Iron, iron everywhere but not enough to donate. Transfusion 2002; 42:664-665 (Editorial)
13. Brittenham GM, Gordenuk VR, Bravo JR: Carbonyl iron supplementation for female blood donors. Blood 1996; 88:89b
14. Radtke H, Tegtmeier J, Rocker L, Salama A, Kiesewetter H: Daily doses of 20 mg of elemental iron compensate for iron loss in regular donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004; 44:1427-1432
15. Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ: Carbonyl iron for short term supplementation in female blood donors. Transfusion 1987; 27:80-85
16. Oklahoma Blood Institute: Heart Check: 2006; available online: www.obi.org
17. Harris IS: Barnes-Jewish Hospital laboratory reference values; in Green GB, Harris IS, Lin GA, Moylan KC (eds): The Washington Manual of Medical Therapeutics. Philadelphia: Lippincott, Williams & Wilkins, 2004:599-605
18. American Heart Association: Cholesterol Levels: 2006; available online: www.american heart.org
19. Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, Howard J, Hunninghake DB, Illingworth R, Luepker RV, McBride P, McKenny JM, Pasternak RC, Stone NJ, Van Horn L: Executive summary of the third report of the National Cholesterol Educational Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285:2486-2497
20. Frankel S, Davey Smith G, Donovan J, Neal D: Screening for prostate cancer. Lancet 2003; 361:1122-1128
21. UPMC Cancer Centers: Prostate Cancers. Urological Evaluation: 2006; available online: http://www.upmccancercenters.com/cancer/prostate/psaelevated. html
22. Keetch DW, Catalona WJ, Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen levels. J Urol 1994; 152:1571-1574
23. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Scott Lucia PH, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA: Prevalence of prostate cancer among men with a prostate-specific antigen level > 4.0 ng/mL. N Engl J Med 2004; 350:2239-2246
24. National Diabetes Information Clearinghouse: NIDDK. NIH Publication 06-3892, Bethesda, MD, November 2005
25. American Diabetes Association: Diagnosis and classification of diabetes mellitus Diabetes Care 2006; 29:S43-S48
26. MedicineNet: Hemoglobin A1c. 2002 Available online: www.mednet.com/ hemoglobinA1c/article.htm
27. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126
28. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397
29. American Heart Association: Inflammation, Heart Disease and Stroke: the Role of C-reactive Protein. Available online at: www.americanheart.org
30. Mosca L: C-reactive protein - to screen or not to screen. N Engl J Med 2002; 347:1615-1617 (Editorial)
31. American Heart Association: Homocysteine, Folic Acid and Cardiovascular Disease. Available online at: www.americanheart.org
32. Tanne D, Haim M, Golbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA: Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003; 34:632-636
33. Loscalzo J: Homocysteine trials - clear outcomes for complex reasons. N Engl J Med 2006; 354:1629-1632 (Editorial)
34. Leitman SF, Browning JN, Yau YY, Mason G, Klein HG, Conry-Cantilena C, Bolan C: Hemochromatosis subjects as allogeneic blood donors: a prospective study. Transfusion 2003; 43:1538-1544
35. Newman B: Hemochromatosis blood donor programs: marginal for the blood supply but potentially good for patient care. Transfusion 2004; 10:1535-1537
36. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T: Penetrance of 845G→A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002; 359:211-218
37. Qaseem A, Aronson M, Fitterman N, Snow V, Weiss KB, Owens DK: Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Int Med 2005; 143:517-521
38. Geringer W, Martin-Prendergast S, Valinsky J, Davey R, Louie J, Thompson J, Kessler D, Jones R: Genetic screening for hereditary hemochromatosis (HH) by a community blood center. Transfusion 2003; 43S:10A